Back to Top
Lesigercept Biosimilar - Research Grade
$710.00 - $6,900.00
Lesigercept Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
IGHEï؟½
Concentration
5mg/ml
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P01854
Shipping Conditions
Blue ice
Background
Immunoglobulin E (IgE), encoded by IGHE, is the antibody isotype that drives allergic sensitization and mast-cell activation, making it a long-standing target in allergy research. This reagent is an unconjugated, non-therapeutic analog of lesigercept designed to engage IgE for functional studies. It is provided in a low-endotoxin format suited to in vivo experiments and produced in scalable milligram-to-gram quantities so that bulk and high-throughput laboratories are well supplied. For research use only (RUO), it is useful as a control and active reagent in IgE-neutralization assays, mast-cell and basophil activation readouts, in vitro screening, and preclinical models of allergic disease.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review












